A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in United Therapeutics Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 5,104 shares of UTHR stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,104
Previous 7,980 36.04%
Holding current value
$1.84 Million
Previous $2.54 Million 28.05%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $894,551 - $1.05 Million
-2,876 Reduced 36.04%
5,104 $1.83 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $1.82 Million - $2.55 Million
7,980 New
7,980 $2.54 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.